Cdc Riser Industry Day Tender

• Country: USA
• Summary: Cdc Riser Industry Day
• UST Ref No: 139363223
• Deadline: 06 May 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 75D301-TBD-RISER
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Industry Day Announcement
  75D301-TBD-RISER
  CDC Industry Day
  Title: Resources for the Improvement of Surveillance and Emergency Response Program (RISER)
  NAICS: 325413 - In-Vitro Diagnostic Substance Manufacturing
  541511 - Custom Computer Programming Services
  Point of Contact: RISER team- riseridiq@cdc.gov (Attn: Adam Dwyer)
  Short Description: This project is a critical component of CDC-s efforts to ensure the availability and distribution of quality reference pathogens and other reagents to CDC and partner researchers for surveillance and public health responses. It also serves to enhance the CDC-s ability to provide on-site technical assistance to state and local public health laboratories and commercial developers of vaccines, antiviral drugs, and diagnostic tests; in support of our common goal to minimize the impact of bacterial, viral, and respiratory diseases in humans. Further, it builds on successful platforms to expand the network of CDC laboratories that can use this mechanism to further protect the safety and health of Americans.
  The primary core objectives of this contract are:
  To produce or acquire high-quality stocks of reference pathogens, positive controls, detection kits, genomic sequencing components, proficiency panels, and other similar types of surveillance and research reagents in direct support of CDC-developed assays and surveillance platforms;
  To ensure that these reagents, and any other materials critical to the performance of public health laboratory surveillance activities, are reliably available to CDC, its public health laboratory partners, and approved research collaborators for the characterization of circulating and novel pathogens;
  To sustain the operational capacity to rapidly scale reagent acquisition, production, and distribution in support of domestic and global public health emergencies;
  To establish and maintain secure infrastructure for real-time data exchange across contractors and with...
• Documents:

 Tender Notice

Documents.zip